Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence summary HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS FPKM FPKM max in non-specific ABCA7 ABCX ENSG00000064687 ATP-binding cassette, sub-family A (ABC1), member 7 19 1040101-1065572 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041564 Supportive Supportive Plasma membrane, Golgi apparatus, Cell Junctions Expressed in all bone marrow: 22.3 ABCB11 ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP ENSG00000073734 ATP-binding cassette, sub-family B (MDR/TAP), member 11 2 168922938-169031322 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019035 Supportive Uncertain Nucleus but not nucleoli, Plasma membrane, Cytoplasm Tissue enriched 8 liver: 14.0 testis: 1.8 ABCC1 GS-X, MRP, MRP1 ENSG00000103222 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 16 15949577-16143074 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002380 Uncertain Supportive Plasma membrane Expressed in all testis: 19.3 ABCC11 MRP8 ENSG00000121270 ATP-binding cassette, sub-family C (CFTR/MRP), member 11 16 48166910-48247568 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031980, HPA031981, HPA031982, CAB032513 Supportive Tissue enhanced 0 prostate: 1.3;testis: 2.5 fallopian tube: 0.5 ABCC2 CMOAT, cMRP, DJS, MRP2 ENSG00000023839 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 10 99782732-99852192 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004860, CAB037271 Supportive Group enriched 24 duodenum: 30.2;gallbladder: 24.7;kidney: 12.5;liver: 39.4;small intestine: 31.7 skin: 1.1 ABCC3 cMOAT2, EST90757, MLP2, MOAT-D, MRP3 ENSG00000108846 ATP-binding cassette, sub-family C (CFTR/MRP), member 3 17 50634777-50692252 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037136, HPA048483 Supportive Uncertain Plasma membrane Mixed gallbladder: 16.8 ABCC4 EST170205, MOAT-B, MOATB, MRP4 ENSG00000125257 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 13 95019829-95301433 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002476 Supportive Uncertain Nucleoli, Plasma membrane, Cytoplasm Tissue enhanced 0 prostate: 41.8 urinary bladder: 19.3 ABCC5 EST277145, MOAT-C, MRP5, SMRP ENSG00000114770 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 3 183919934-184018015 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044067, HPA052295 Uncertain Supportive Plasma membrane, Nucleus, Cell Junctions Expressed in all stomach: 34.9 ABCC6 ARA, EST349056, MLP1, MRP6, PXE, URG7 ENSG00000091262 ATP-binding cassette, sub-family C (CFTR/MRP), member 6 16 16148928-16223522 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038105 Supportive Plasma membrane Tissue enhanced 0 liver: 29.2 kidney: 20.8 ADCY2 AC2, HBAC2, KIAA1060 ENSG00000078295 Adenylate cyclase 2 (brain) 5 7396208-7830081 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB031482, HPA038015, HPA038483 Supportive Uncertain Golgi apparatus, Vesicles Tissue enhanced 0 cerebral cortex: 38.9;skeletal muscle: 23.0 skin: 11.8 ADCY8 AC8, ADCY3, HBAC1 ENSG00000155897 Adenylate cyclase 8 (brain) 8 130780301-131042426 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018652, HPA024291 Supportive Group enriched 8 cerebral cortex: 6.6;fallopian tube: 4.5;lung: 1.5 smooth muscle: 0.5 ALG6 ENSG00000088035 ALG6, alpha-1,3-glucosyltransferase 1 63367590-63438562 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062536 Supportive Endoplasmic reticulum Expressed in all tonsil: 9.2 ANO6 DKFZp313M0720, TMEM16F ENSG00000177119 Anoctamin 6 12 45215987-45440404 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038958 Uncertain Expressed in all adipose tissue: 61.6 ATP10D ATPVD, KIAA1487 ENSG00000145246 ATPase, class V, type 10D 4 47485288-47593486 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA050808 Uncertain Supportive Nucleus but not nucleoli, Plasma membrane Mixed placenta: 10.1 ATP11A ATPIH, ATPIS, KIAA1021 ENSG00000068650 ATPase, class VI, type 11A 13 112690329-112887168 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035583, HPA035584 Uncertain Supportive Vesicles Expressed in all lung: 36.1 ATP13A2 CLN12, HSA9947, PARK9 ENSG00000159363 ATPase type 13A2 1 16985958-17011928 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037038, CAB037111, HPA050910, HPA054717 Supportive Expressed in all cerebral cortex: 32.7 ATP1A3 DYT12 ENSG00000105409 ATPase, Na+/K+ transporting, alpha 3 polypeptide 19 41966582-41997497 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033630, HPA045367, HPA056446 Supportive Tissue enhanced 0 cerebral cortex: 183.9;heart muscle: 70.4 testis: 36.0 ATP2A1 ATP2A, SERCA1 ENSG00000196296 ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 16 28878405-28904509 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002310, CAB032706 Supportive Uncertain Endoplasmic reticulum Tissue enriched 86 skeletal muscle: 2022.5 esophagus: 23.5 ATP2A2 ATP2B, DAR, SERCA2 ENSG00000174437 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 12 110280756-110351093 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062605, HPA067892 Uncertain Supportive Nucleus but not nucleoli Expressed in all skeletal muscle: 733.0 ATP2B1 PMCA1 ENSG00000070961 ATPase, Ca++ transporting, plasma membrane 1 12 89588049-89709300 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005605, HPA011166, HPA012945 Supportive Supportive Plasma membrane, Nucleus, Nucleoli, Cytoplasm Expressed in all cerebral cortex: 63.2 ATP2B2 PMCA2 ENSG00000157087 ATPase, Ca++ transporting, plasma membrane 2 3 10324023-10708031 Enzymes, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005606 Supportive Tissue enhanced 0 cerebral cortex: 32.0;salivary gland: 11.4 skeletal muscle: 5.4 ATP2B3 CFAP39, CLA2, PMCA3, SCAX1 ENSG00000067842 ATPase, Ca++ transporting, plasma membrane 3 X 153517676-153582939 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001583 Supportive Supportive Plasma membrane, Golgi apparatus Group enriched 6 adrenal gland: 7.2;cerebral cortex: 9.2 fallopian tube: 1.2 ATP2B4 ATP2B2, MXRA1, PMCA4 ENSG00000058668 ATPase, Ca++ transporting, plasma membrane 4 1 203626561-203744081 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016118, HPA040431 Supportive Supportive Plasma membrane Expressed in all smooth muscle: 147.8 ATP2C1 ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1 ENSG00000017260 ATPase, Ca++ transporting, type 2C, member 1 3 130850595-131016712 Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010207, HPA035116, HPA053533 Supportive Uncertain Cytoplasm, Nucleus, Golgi apparatus Expressed in all prostate: 72.0 ATP4A ATP6A ENSG00000105675 ATPase, H+/K+ exchanging, alpha polypeptide 19 35550043-35563658 Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039154 Supportive Tissue enriched 196 stomach: 361.8 pancreas: 1.8 ATP8A1 ATPIA ENSG00000124406 ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 4 42408373-42657105 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049948, HPA052935 Uncertain Supportive Vesicles Expressed in all thyroid gland: 34.7 ATP8B1 ATPIC, BRIC, FIC1, PFIC, PFIC1 ENSG00000081923 ATPase, aminophospholipid transporter, class I, type 8B, member 1 18 57646426-57803101 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018673, HPA018674 Supportive Uncertain Nucleus, Plasma membrane, Cytoplasm Mixed colon: 77.5 ATP9A ATPIIA, KIAA0611 ENSG00000054793 ATPase, class II, type 9A 20 51596514-51768634 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020699, HPA035630, HPA055795 Uncertain Supportive Nucleus, Nucleoli Expressed in all cerebral cortex: 79.6 CACNA1A APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6 ENSG00000141837 Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 19 13206442-13623990 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064258 Supportive Uncertain Golgi apparatus, Vesicles, Nucleus but not nucleoli Tissue enhanced 0 cerebral cortex: 7.9;stomach: 4.9 adrenal gland: 1.5 CACNA1C CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS ENSG00000151067 Calcium channel, voltage-dependent, L type, alpha 1C subunit 12 1970786-2697950 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039796 Supportive Tissue enhanced 0 heart muscle: 17.7;smooth muscle: 17.2 endometrium: 12.7 CACNA1S CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5 ENSG00000081248 Calcium channel, voltage-dependent, L type, alpha 1S subunit 1 201039512-201112566 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009507, HPA048892, HPA056815 Supportive Tissue enriched 31 skeletal muscle: 76.8 esophagus: 2.4 CFTR ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR ENSG00000001626 Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) 7 117465784-117715971 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001951, HPA021939 Supportive Tissue enhanced 0 gallbladder: 51.1;pancreas: 41.7 rectum: 36.9 CLCN2 ClC-2, CLC2, EJM6 ENSG00000114859 Chloride channel, voltage-sensitive 2 3 184346185-184361651 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009397, HPA014545, HPA024108 Supportive Mixed testis: 13.5 CLCN5 ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN ENSG00000171365 Chloride channel, voltage-sensitive 5 X 49922615-50099235 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000401, HPA003213 Uncertain Supportive Plasma membrane, Cytoplasm, Golgi apparatus Tissue enriched 6 kidney: 31.3 liver: 5.4 CLCN7 CLC-7, CLC7, OPTA2, PPP1R63 ENSG00000103249 Chloride channel, voltage-sensitive 7 16 1444934-1475580 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043019, HPA043586 Supportive Supportive Nucleus but not nucleoli Expressed in all spleen: 19.6 DHCR7 SLOS ENSG00000172893 7-dehydrocholesterol reductase 11 71428193-71452868 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044280 Uncertain Supportive Endoplasmic reticulum, Cytoplasm Expressed in all liver: 74.3 HHATL C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3 ENSG00000010282 Hedgehog acyltransferase-like 3 42692663-42702827 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA018174 Supportive Group enriched 8 heart muscle: 260.7;skeletal muscle: 57.4 cerebral cortex: 19.5 KIAA0195 TMEM94 ENSG00000177728 KIAA0195 17 75441159-75500090 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008423, HPA050660 Uncertain Supportive Nucleus but not nucleoli Expressed in all fallopian tube: 38.1 MFSD11 FLJ20226, FLJ22196 ENSG00000092931 Major facilitator superfamily domain containing 11 17 76735865-76781449 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA022001 Uncertain Supportive Nucleus but not nucleoli, Cytoplasm Expressed in all rectum: 16.9 MFSD2A FLJ14490, MFSD2 ENSG00000168389 Major facilitator superfamily domain containing 2A 1 39955112-39969968 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043107 Uncertain Supportive Cytoplasm, Plasma membrane Mixed testis: 37.9 MFSD2B ENSG00000205639 Major facilitator superfamily domain containing 2B 2 24010081-24063321 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA044145 Supportive Uncertain Nucleus but not nucleoli Tissue enriched 10 bone marrow: 6.2 placenta: 0.6 MFSD8 CLN7, MGC33302 ENSG00000164073 Major facilitator superfamily domain containing 8 4 127917805-127965995 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044802 Uncertain Supportive Nucleus but not nucleoli, Vesicles Expressed in all skin: 6.4 MT-CO1 COI, COX1, MTCO1 ENSG00000198804 Mitochondrially encoded cytochrome c oxidase I MT 5904-7445 Disease related genes, Enzymes, Mitochondrial proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016241, HPA069328 Supportive Supportive Mitochondria Expressed in all heart muscle: 59869.8 NNT ENSG00000112992 Nicotinamide nucleotide transhydrogenase 5 43602692-43707405 Disease related genes, Enzymes, Mitochondrial proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004829, CAB004975 Supportive Supportive Mitochondria Expressed in all heart muscle: 109.4 NPC1L1 ENSG00000015520 NPC1-like 1 7 44512535-44541315 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB070127, CAB070128 Supportive Group enriched 5 duodenum: 41.0;liver: 12.2;small intestine: 38.0 gallbladder: 6.0 PIGN MDC4, PIG-N ENSG00000197563 Phosphatidylinositol glycan anchor biosynthesis, class N 18 62043567-62187118 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039922, HPA040374 Supportive Supportive Plasma membrane, Cytoplasm Expressed in all esophagus: 22.4 PKDREJ ENSG00000130943 Polycystin (PKD) family receptor for egg jelly 22 46255663-46263355 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA034587 Supportive Tissue enriched 7 testis: 3.0 skin: 0.4 RHCG C15orf6, PDRC2, RHGK, SLC42A3 ENSG00000140519 Rh family, C glycoprotein 15 89471398-89496613 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041874, HPA043317 Supportive Tissue enriched 6 esophagus: 2099.0 tonsil: 381.2 SCN2A HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2 ENSG00000136531 Sodium channel, voltage-gated, type II, alpha subunit 2 165239402-165392308 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022567 Supportive Tissue enriched 18 cerebral cortex: 31.4 kidney: 1.7 SERINC5 C5orf12, TPO1 ENSG00000164300 Serine incorporator 5 5 80111651-80256079 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA037898, HPA037899 Supportive Uncertain Golgi apparatus, Vesicles, Nucleus Expressed in all testis: 32.2 SLC11A2 DCT1, DMT1, NRAMP2 ENSG00000110911 Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 12 50979401-51028566 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032139, HPA032140 Uncertain Supportive Mitochondria Expressed in all duodenum: 45.0 SLC12A1 NKCC2 ENSG00000074803 Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 15 48191664-48304078 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014967, HPA018107 Supportive Uncertain Nucleus but not nucleoli, Cytoplasm Tissue enriched 597 kidney: 365.5 testis: 0.6 SLC12A3 NCCT ENSG00000070915 Solute carrier family 12 (sodium/chloride transporter), member 3 16 56865207-56915850 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028748 Supportive Tissue enriched 134 kidney: 101.6 lymph node: 0.7 SLC12A5 KCC2, KIAA1176 ENSG00000124140 Solute carrier family 12 (potassium/chloride transporter), member 5 20 46021717-46060150 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA072058 Supportive Tissue enriched 49 cerebral cortex: 36.6 adrenal gland: 0.7 SLC12A8 CCC9 ENSG00000221955 Solute carrier family 12, member 8 3 125082636-125212864 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA031123 Uncertain Supportive Nucleus but not nucleoli Tissue enhanced 0 thyroid gland: 20.3 gallbladder: 11.0 SLC13A2 NaDC-1 ENSG00000007216 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 17 28473293-28497781 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014963 Supportive Group enriched 8 duodenum: 53.6;kidney: 18.0;salivary gland: 13.3;small intestine: 39.4 gallbladder: 3.8 SLC13A3 NADC3, SDCT2 ENSG00000158296 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 20 46557823-46684467 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014353, HPA014736 Supportive Tissue enriched 7 kidney: 289.3 placenta: 42.2 SLC15A3 hPTR3, PHT2 ENSG00000110446 Solute carrier family 15 (oligopeptide transporter), member 3 11 60937083-60952530 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA047880, HPA057642 Uncertain Supportive Vesicles Expressed in all lung: 66.0 SLC15A4 PHT1, PTR4 ENSG00000139370 Solute carrier family 15 (oligopeptide transporter), member 4 12 128793191-128823983 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA016713 Uncertain Supportive Nucleus but not nucleoli Expressed in all bone marrow: 28.9 SLC16A1 MCT, MCT1 ENSG00000155380 Solute carrier family 16 (monocarboxylate transporter), member 1 1 112911847-112957013 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003324, CAB017489 Uncertain Supportive Plasma membrane Expressed in all colon: 40.3 SLC16A13 MCT13 ENSG00000174327 Solute carrier family 16, member 13 17 7036075-7040121 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA065245 Supportive Golgi apparatus Tissue enhanced 0 liver: 13.9 duodenum: 6.4 SLC16A3 MCT3, MCT4 ENSG00000141526 Solute carrier family 16 (monocarboxylate transporter), member 3 17 82228397-82261129 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017490, HPA021451 Uncertain Supportive Plasma membrane, Nuclear membrane, Cytoskeleton (Microtubules) Expressed in all skeletal muscle: 55.7 SLC17A5 AST, ISSD, NSD, SD, SIALIN, SIASD, SLD ENSG00000119899 Solute carrier family 17 (acidic sugar transporter), member 5 6 73593379-73654155 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044479 Uncertain Supportive Plasma membrane, Cytoplasm Expressed in all thyroid gland: 40.7 SLC17A6 DNPI, VGLUT2 ENSG00000091664 Solute carrier family 17 (vesicular glutamate transporter), member 6 11 22338097-22379503 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037130, HPA039226 Supportive Tissue enriched 34 cerebral cortex: 3.3 adipose tissue: 0.0 SLC17A7 BNPI, VGLUT1 ENSG00000104888 Solute carrier family 17 (vesicular glutamate transporter), member 7 19 49429401-49442360 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037183, HPA050458, HPA063679 Supportive Tissue enriched 137 cerebral cortex: 291.7 adipose tissue: 2.1 SLC18B1 C6orf192, dJ55C23.6 ENSG00000146409 Solute carrier family 18, subfamily B, member 1 6 132769370-132798553 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029747, HPA049659 Uncertain Supportive Cytoplasm, Golgi apparatus Expressed in all cerebral cortex: 18.3 SLC1A2 EAAT2, GLT-1 ENSG00000110436 Solute carrier family 1 (glial high affinity glutamate transporter), member 2 11 35251206-35420063 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002574, HPA009172 Supportive Tissue enriched 16 cerebral cortex: 195.0 liver: 12.0 SLC1A3 EA6, EAAT1, GLAST ENSG00000079215 Solute carrier family 1 (glial high affinity glutamate transporter), member 3 5 36606355-36688334 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002573, HPA037467, HPA037468 Supportive Uncertain Mitochondria, Nucleoli Tissue enriched 13 cerebral cortex: 269.2 adipose tissue: 20.0 SLC1A6 EAAT4 ENSG00000105143 Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 19 14950034-15022990 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041505, HPA044066 Supportive Group enriched 22 cerebral cortex: 8.0;skin: 5.1;testis: 22.2 placenta: 0.5 SLC22A12 OAT4L, RST, URAT1 ENSG00000197891 Solute carrier family 22 (organic anion/urate transporter), member 12 11 64590641-64602353 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024575 Supportive Tissue enriched 343 kidney: 105.4 adipose tissue: 0.3 SLC22A13 OAT10, OCTL1, OCTL3, ORCTL3 ENSG00000172940 Solute carrier family 22 (organic anion/urate transporter), member 13 3 38265812-38278315 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA035603, HPA035962 Supportive Tissue enriched 61 kidney: 8.9 testis: 0.1 SLC22A15 FLIPT1 ENSG00000163393 Solute carrier family 22, member 15 1 115976498-116070054 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019785 Supportive Uncertain Vesicles Tissue enhanced 0 bone marrow: 10.5 skin: 5.8 SLC22A2 OCT2 ENSG00000112499 Solute carrier family 22 (organic cation transporter), member 2 6 160171061-160277638 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008567, CAB068236, CAB068237 Supportive Tissue enriched 297 kidney: 81.8 cerebral cortex: 0.2 SLC22A8 OAT3 ENSG00000149452 Solute carrier family 22 (organic anion transporter), member 8 11 62989154-63015839 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044174 Supportive Tissue enriched 764 kidney: 255.1 cerebral cortex: 0.3 SLC23A1 SLC23A2, SVCT1, YSPL3 ENSG00000170482 Solute carrier family 23 (ascorbic acid transporter), member 1 5 139367196-139384553 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047612 Supportive Tissue enhanced 0 fallopian tube: 49.2;kidney: 32.8;small intestine: 47.7 duodenum: 18.4 SLC23A2 KIAA0238, SLC23A1, SVCT2, YSPL2 ENSG00000089057 Solute carrier family 23 (ascorbic acid transporter), member 2 20 4852356-5010293 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052825, HPA059314 Uncertain Supportive Vesicles, Golgi apparatus Expressed in all adrenal gland: 64.4 SLC26A11 ENSG00000181045 Solute carrier family 26 (anion exchanger), member 11 17 80219699-80253500 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA029893 Uncertain Supportive Golgi apparatus, Vesicles, Nucleus but not nucleoli Expressed in all adrenal gland: 16.5 SLC26A2 DTD, DTDST ENSG00000155850 Solute carrier family 26 (anion exchanger), member 2 5 149960737-149993455 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041957, HPA058090 Supportive Uncertain Vesicles Group enriched 6 colon: 182.5;rectum: 163.7 adrenal gland: 27.9 SLC28A1 CNT1 ENSG00000156222 Solute carrier family 28 (concentrative nucleoside transporter), member 1 15 84884654-84945796 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019551 Supportive Group enriched 30 duodenum: 22.9;kidney: 30.6;liver: 19.2;small intestine: 30.7 placenta: 0.8 SLC28A2 CNT2, HCNT2, HsT17153, SPNT1 ENSG00000137860 Solute carrier family 28 (concentrative nucleoside transporter), member 2 15 45252230-45277845 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA046068, HPA055623 Supportive Tissue enhanced 0 duodenum: 45.8;rectum: 28.2;small intestine: 67.8 stomach: 15.2 SLC29A1 ENT1 ENSG00000112759 Solute carrier family 29 (equilibrative nucleoside transporter), member 1 6 44219505-44234151 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012383, HPA012384 Uncertain Supportive Nucleus but not nucleoli Expressed in all adrenal gland: 78.3 SLC29A4 ENT4, FLJ34923 ENSG00000164638 Solute carrier family 29 (equilibrative nucleoside transporter), member 4 7 5274369-5306870 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA052829 Supportive Cytoskeleton (Microtubules), Cytoskeleton (Cytokinetic bridge) Tissue enriched 5 adipose tissue: 28.8 adrenal gland: 5.5 SLC2A1 DYT18, GLUT, GLUT1, HTLVR ENSG00000117394 Solute carrier family 2 (facilitated glucose transporter), member 1 1 42925381-42958859 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002759, HPA031345, HPA058494 Supportive Supportive Supportive Plasma membrane Tissue enhanced 0 placenta: 448.5 skin: 96.3 SLC2A10 GLUT10 ENSG00000197496 Solute carrier family 2 (facilitated glucose transporter), member 10 20 46709487-46736347 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041015, HPA055673 Uncertain Supportive Cytoplasm Mixed prostate: 24.5 SLC2A14 GLUT14, SLC2A3P3 ENSG00000173262 Solute carrier family 2 (facilitated glucose transporter), member 14 12 7812512-7891148 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA006539 Supportive Uncertain Plasma membrane Group enriched 6 bone marrow: 12.9;testis: 62.2 urinary bladder: 6.5 SLC2A2 GLUT2 ENSG00000163581 Solute carrier family 2 (facilitated glucose transporter), member 2 3 170996348-171026750 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010444, HPA028997 Supportive Tissue enriched 5 liver: 245.1 duodenum: 48.3 SLC2A3 GLUT3 ENSG00000059804 Solute carrier family 2 (facilitated glucose transporter), member 3 12 7919230-7936275 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002763, HPA006539 Uncertain Uncertain Plasma membrane Tissue enhanced 0 bone marrow: 245.9 placenta: 89.6 SLC2A4 GLUT4 ENSG00000181856 Solute carrier family 2 (facilitated glucose transporter), member 4 17 7281667-7288257 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016544 Supportive Tissue enhanced 0 heart muscle: 31.2;skeletal muscle: 37.6 adipose tissue: 15.7 SLC30A5 FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1 ENSG00000145740 Solute carrier family 30 (zinc transporter), member 5 5 69093646-69131069 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035373 Uncertain Supportive Golgi apparatus, Nucleus Expressed in all thyroid gland: 34.2 SLC32A1 bA122O1.1, VGAT, VIAAT ENSG00000101438 Solute carrier family 32 (GABA vesicular transporter), member 1 20 38724462-38729372 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037156, HPA058859, HPA059985 Supportive Tissue enriched 28 cerebral cortex: 7.4 testis: 0.2 SLC35C1 FLJ11320, FUCT1 ENSG00000181830 Solute carrier family 35 (GDP-fucose transporter), member C1 11 45804072-45813015 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064001 Supportive Supportive Golgi apparatus Expressed in all esophagus: 22.3 SLC35C2 bA394O2.1, C20orf5, CGI-15, OVCOV1 ENSG00000080189 Solute carrier family 35 (GDP-fucose transporter), member C2 20 46345980-46364458 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA027011 Uncertain Supportive Nucleus, Golgi apparatus Expressed in all fallopian tube: 24.3 SLC35E1 FLJ14251 ENSG00000127526 Solute carrier family 35, member E1 19 16549831-16572382 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016570, HPA062214 Uncertain Supportive Golgi apparatus Expressed in all prostate: 16.0 SLC36A2 PAT2, TRAMD1, tramdorin ENSG00000186335 Solute carrier family 36 (proton/amino acid symporter), member 2 5 151314978-151347590 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044002, HPA062229 Supportive Group enriched 62 kidney: 46.6;skeletal muscle: 20.4 testis: 0.5 SLC37A1 ENSG00000160190 Solute carrier family 37 (glucose-6-phosphate transporter), member 1 21 42496008-42581440 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030418, CAB034154 Supportive Uncertain Nucleus Expressed in all duodenum: 29.8 SLC37A3 DKFZp761N0624 ENSG00000157800 Solute carrier family 37, member 3 7 140293693-140404433 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA014713, HPA061841 Uncertain Supportive Cytoplasm Expressed in all endometrium: 41.7 SLC37A4 G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d ENSG00000137700 Solute carrier family 37 (glucose-6-phosphate transporter), member 4 11 119024114-119030906 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038939, HPA038940 Supportive Uncertain Mitochondria Expressed in all duodenum: 37.2 SLC38A10 MGC15523, PP1744 ENSG00000157637 Solute carrier family 38, member 10 17 81245000-81295547 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021374, HPA023161, HPA024631 Supportive Expressed in all spleen: 27.2 SLC38A7 FLJ10815 ENSG00000103042 Solute carrier family 38, member 7 16 58665109-58685104 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041777 Uncertain Uncertain Plasma membrane, Cytoplasm, Nucleus but not nucleoli Expressed in all testis: 20.0 SLC43A1 PB39, POV1, R00504 ENSG00000149150 Solute carrier family 43 (amino acid system L transporter), member 1 11 57484534-57515786 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA018813, HPA018826 Supportive Uncertain Plasma membrane, Golgi apparatus, Vesicles Expressed in all pancreas: 50.5 SLC44A1 CD92, CDW92, CHTL1, CTL1 ENSG00000070214 Solute carrier family 44 (choline transporter), member 1 9 105244622-105439171 CD markers, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064714 Supportive Mitochondria, Nucleus but not nucleoli Expressed in all cerebral cortex: 56.0 SLC44A4 C6orf29, CTL4, FLJ14491, NG22, TPPT ENSG00000204385 Solute carrier family 44, member 4 6 31863192-31879046 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA046977, HPA054176 Supportive Mixed rectum: 166.8 SLC45A3 IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein ENSG00000158715 Solute carrier family 45, member 3 1 205657851-205680459 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019073, HPA019075 Supportive Uncertain Vesicles, Nucleus but not nucleoli Tissue enriched 24 prostate: 334.9 stomach: 14.0 SLC46A1 HCP1, MGC9564, PCFT ENSG00000076351 Solute carrier family 46 (folate transporter), member 1 17 28394756-28407197 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011614 Uncertain Supportive Plasma membrane, Cytoplasm Expressed in all duodenum: 65.8 SLC4A1 AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR ENSG00000004939 Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) 17 44248385-44268141 Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015584, CAB034438, HPA063911 Supportive Tissue enriched 8 bone marrow: 206.1 kidney: 26.0 SLC4A10 NBCn2, NCBE ENSG00000144290 Solute carrier family 4, sodium bicarbonate transporter, member 10 2 161424332-161985282 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA034755 Supportive Tissue enriched 18 cerebral cortex: 31.7 adrenal gland: 1.7 SLC4A2 AE2, BND3L, EPB3L1, HKB3, NBND3 ENSG00000164889 Solute carrier family 4 (anion exchanger), member 2 7 151057210-151076527 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019339 Supportive Uncertain Nucleus but not nucleoli, Plasma membrane, Cytoplasm Expressed in all stomach: 32.2 SLC4A4 hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5 ENSG00000080493 Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 4 71187286-71572087 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022493, HPA035628, HPA035629 Supportive Tissue enhanced 0 kidney: 76.4 pancreas: 61.6 SLC4A7 NBC3, SBC2, SLC4A6 ENSG00000033867 Solute carrier family 4, sodium bicarbonate cotransporter, member 7 3 27372721-27484420 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022494, HPA035857 Supportive Supportive Plasma membrane, Cytoplasm, Focal Adhesions Expressed in all duodenum: 46.7 SLC5A1 D22S675, NAGT, SGLT1 ENSG00000100170 Solute carrier family 5 (sodium/glucose cotransporter), member 1 22 32043032-32113029 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015467, HPA051805, HPA055106 Supportive Group enriched 12 duodenum: 380.8;small intestine: 221.3 gallbladder: 25.5 SLC5A12 MGC52019, SMCT2 ENSG00000148942 Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 11 26667019-26723427 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA060904 Supportive Group enriched 17 kidney: 105.7;small intestine: 24.7 duodenum: 3.8 SLC5A2 SGLT2 ENSG00000140675 Solute carrier family 5 (sodium/glucose cotransporter), member 2 16 31483002-31490860 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041603 Supportive Tissue enriched 27 kidney: 35.2 testis: 1.3 SLC5A5 NIS ENSG00000105641 Solute carrier family 5 (sodium/iodide cotransporter), member 5 19 17871973-17895174 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB022364, HPA049055 Supportive Group enriched 73 salivary gland: 30.3;stomach: 40.7;thyroid gland: 10.2 testis: 0.3 SLC6A1 GABATHG, GABATR, GAT1 ENSG00000157103 Solute carrier family 6 (neurotransmitter transporter), member 1 3 10992724-11039247 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013341, CAB022293 Supportive Uncertain Mitochondria Group enriched 9 cerebral cortex: 57.7;liver: 33.4 testis: 4.8 SLC6A11 GAT3 ENSG00000132164 Solute carrier family 6 (neurotransmitter transporter), member 11 3 10816200-10940733 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA037981 Supportive Tissue enhanced 0 cerebral cortex: 9.1;esophagus: 4.1;skin: 4.0 testis: 1.5 SLC6A18 FLJ31236, Xtrp2 ENSG00000164363 Solute carrier family 6 (neutral amino acid transporter), member 18 5 1225355-1246189 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA011885 Supportive Tissue enriched 83 kidney: 8.2 adipose tissue: 0.0 SLC6A19 ENSG00000174358 Solute carrier family 6 (neutral amino acid transporter), member 19 5 1201595-1225117 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037415, HPA043207 Supportive Group enriched 21 duodenum: 99.4;kidney: 82.0;small intestine: 103.4 rectum: 4.5 SLC6A6 TAUT ENSG00000131389 Solute carrier family 6 (neurotransmitter transporter), member 6 3 14402576-14489349 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015028, HPA016488 Supportive Expressed in all bone marrow: 27.5 SLC7A5 CD98, D16S469E, E16, LAT1, MPE16 ENSG00000103257 Solute carrier family 7 (amino acid transporter light chain, L system), member 5 16 87830023-87869488 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052673, HPA056077 Uncertain Supportive Plasma membrane, Cytoplasm, Vesicles Expressed in all testis: 57.1 SLC7A8 LAT2, LPI-PC1 ENSG00000092068 Solute carrier family 7 (amino acid transporter light chain, L system), member 8 14 23125295-23183674 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB046015, HPA051950, HPA060672 Supportive Expressed in all kidney: 103.7 SLC7A9 CSNU3 ENSG00000021488 Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 19 32830509-32869766 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042591 Supportive Group enriched 10 duodenum: 53.3;kidney: 43.2;small intestine: 80.0 liver: 5.6 SLC9A1 APNH, NHE1, PPP1R143 ENSG00000090020 Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 1 27098815-27166981 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022371, HPA048532, HPA052891 Supportive Supportive Plasma membrane, Nucleus but not nucleoli Expressed in all stomach: 53.0 SLC9A3 NHE3 ENSG00000066230 Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 5 473310-524332 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036493, HPA036669 Supportive Supportive Plasma membrane Group enriched 7 colon: 64.5;duodenum: 28.1;gallbladder: 38.8;kidney: 63.2;small intestine: 45.8;stomach: 35.6 appendix: 6.2 SLC9A5 NHE5 ENSG00000135740 Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 16 67237683-67272190 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA041004, HPA041329 Supportive Uncertain Cytoplasm, Nucleus but not nucleoli Tissue enhanced 0 spleen: 4.0 cerebral cortex: 1.5 SLC9A6 KIAA0267, NHE6 ENSG00000198689 Solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 X 135985439-136047264 Disease related genes, Mitochondrial proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059445, HPA059590 Uncertain Supportive Vesicles Expressed in all cerebral cortex: 37.8 SLCO1B1 LST-1, OATP-C, OATP1B1, SLC21A6 ENSG00000134538 Solute carrier organic anion transporter family, member 1B1 12 21131202-21239246 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050892 Supportive Tissue enriched 455 liver: 143.5 gallbladder: 0.3 SLCO1B3 OATP1B3, OATP8, SLC21A8 ENSG00000111700 Solute carrier organic anion transporter family, member 1B3 12 20810702-20916911 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004943, HPA050892 Supportive Tissue enriched 51 liver: 45.1 testis: 0.8 SLCO6A1 CT48, MGC26949, OATP6A1, OATPY ENSG00000205359 Solute carrier organic anion transporter family, member 6A1 5 102371782-102499016 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA054126 Supportive Tissue enriched 214 testis: 24.4 placenta: 0.1 SPNS1 HSpin1, LAT, nrs, PP2030, SPIN1, SPINL ENSG00000169682 Spinster homolog 1 (Drosophila) 16 28974221-28984548 Mitochondrial proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041995, HPA042988 Supportive Uncertain Golgi apparatus, Vesicles, Nucleoli, Cytoplasm Expressed in all placenta: 17.9 STT3B FLJ90106, SIMP, STT3-B ENSG00000163527 STT3B, subunit of the oligosaccharyltransferase complex (catalytic) 3 31532638-31637622 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036448, HPA036646 Uncertain Supportive Endoplasmic reticulum Expressed in all ovary: 85.9 SV2A KIAA0736, SV2 ENSG00000159164 Synaptic vesicle glycoprotein 2A 1 149903318-149917882 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002226, HPA007863 Supportive Supportive Cytoplasm Tissue enriched 11 cerebral cortex: 83.1 adrenal gland: 7.3 SV2C ENSG00000122012 Synaptic vesicle glycoprotein 2C 5 76083172-76353939 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040722, HPA040770 Uncertain Supportive Nucleus, Vesicles Tissue enhanced 0 adrenal gland: 1.1;cerebral cortex: 1.7 ovary: 0.4 TMEM245 C9orf5, CG-2 ENSG00000106771 Transmembrane protein 245 9 109015152-109119945 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023892 Uncertain Uncertain Plasma membrane, Cytoplasm Expressed in all thyroid gland: 74.8 TMEM63B C6orf110, dJ421H19.2, DKFZp434P0531 ENSG00000137216 Transmembrane protein 63B 6 44126914-44155519 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029249, HPA029250, HPA029251 Supportive Supportive Plasma membrane, Cytoskeleton (Actin filaments) Expressed in all lung: 37.3 TPCN2 TPC2 ENSG00000162341 Two pore segment channel 2 11 69048897-69090604 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016561, HPA027080 Supportive Uncertain Nucleoli Expressed in all endometrium: 5.4 UNC93B1 UNC93 ENSG00000110057 Unc-93 homolog B1 (C. elegans) 11 67991104-68004982 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038716, HPA038717, HPA042803 Supportive Uncertain Nucleus but not nucleoli Mixed spleen: 37.3